ServisFirst Bancshares Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
ServisFirst Bancshares Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2017-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | ||||||||||||||||||||||||||
net income | 63,224,000 | 59,907,000 | 52,136,000 | 50,026,000 | 42,074,000 | 53,340,000 | 53,468,000 | 57,971,000 | 67,724,000 | 64,031,000 | 62,136,000 | 57,613,000 | 53,753,000 | 52,499,000 | 50,027,000 | 51,455,000 | 50,981,000 | 43,362,000 | 40,448,000 | 34,778,000 | 41,037,000 | 37,563,000 | 35,633,000 | 35,010,000 | 34,560,000 | 22,519,000 |
adjustments to reconcile net income to net cash from operations | ||||||||||||||||||||||||||
deferred tax expense | 455,000 | -3,928,000 | 424,000 | 1,359,000 | 1,068,000 | -607,000 | ||||||||||||||||||||
benefit from credit losses | 6,630,000 | 6,162,000 | 5,353,000 | 4,368,000 | 3,582,000 | 4,282,000 | 6,654,000 | 4,197,000 | 7,135,000 | 15,603,000 | 9,507,000 | 5,362,000 | 8,451,000 | 5,963,000 | 9,652,000 | 7,451,000 | ||||||||||
depreciation | 1,223,000 | 1,456,000 | 1,140,000 | 1,099,000 | 1,195,000 | 1,099,000 | 1,071,000 | 1,071,000 | 945,000 | 1,057,000 | 1,040,000 | 1,058,000 | 1,044,000 | 1,044,000 | 1,015,000 | 1,015,000 | 1,044,000 | 946,000 | 921,000 | 921,000 | 908,000 | 929,000 | 928,000 | 917,000 | 869,000 | 752,000 |
accretion on acquired loans | 51,000 | 45,000 | 47,000 | 49,000 | 49,000 | 50,000 | 49,000 | 49,000 | 49,000 | 38,000 | 0 | 1,000 | 0 | 0 | -91,000 | -22,000 | -143,000 | |||||||||
amortization of investments in tax credit partnerships | 2,904,000 | 2,118,000 | 1,970,000 | 2,837,000 | 5,239,000 | 2,574,000 | 3,195,000 | 3,345,000 | 2,929,000 | |||||||||||||||||
net accretion of debt securities | -6,000 | |||||||||||||||||||||||||
increase in accrued interest and dividends receivable | -7,665,000 | 1,358,000 | -1,529,000 | -2,226,000 | -2,681,000 | -6,317,000 | 317,000 | -2,078,000 | -8,476,000 | -3,389,000 | 3,218,000 | 493,000 | -234,000 | -5,679,000 | -839,000 | 1,212,000 | 363,000 | -2,928,000 | -3,380,000 | -250,000 | ||||||
stock-based compensation expense | 864,000 | 1,013,000 | 878,000 | 958,000 | 881,000 | 929,000 | 982,000 | 808,000 | 816,000 | 804,000 | 797,000 | 790,000 | 545,000 | 461,000 | 558,000 | 291,000 | 363,000 | 339,000 | 353,000 | 277,000 | 319,000 | 293,000 | 206,000 | 282,000 | 202,000 | 337,000 |
increase in accrued interest and dividends payable | 1,029,000 | 1,288,000 | -1,529,000 | -723,000 | 2,862,000 | 1,622,000 | 2,520,000 | 1,926,000 | ||||||||||||||||||
proceeds from sale of mortgage loans held for sale | 39,104,000 | 59,011,000 | 51,825,000 | 37,635,000 | 35,955,000 | 40,073,000 | 35,354,000 | 16,320,000 | 12,358,000 | 20,729,000 | 8,880,000 | 8,955,000 | 12,538,000 | 49,956,000 | 81,365,000 | 90,227,000 | 90,323,000 | 89,377,000 | 68,873,000 | 36,308,000 | 45,171,000 | 44,645,000 | 29,962,000 | 15,581,000 | 25,977,000 | 32,501,000 |
originations of mortgage loans held for sale | -40,666,000 | -54,938,000 | -54,027,000 | -39,475,000 | -33,903,000 | -41,601,000 | -36,988,000 | -15,922,000 | -11,448,000 | -18,497,000 | -11,314,000 | -7,718,000 | -12,603,000 | -42,964,000 | -68,979,000 | -88,889,000 | -80,226,000 | -93,839,000 | -74,510,000 | -35,672,000 | -41,426,000 | -42,557,000 | -37,098,000 | -16,109,000 | -25,860,000 | -33,526,000 |
gain on sale of mortgage loans held for sale | -613,000 | -1,352,000 | -1,380,000 | -678,000 | -793,000 | -824,000 | -696,000 | -442,000 | -514,000 | -784,000 | -614,000 | -526,000 | -471,000 | -1,423,000 | -2,699,000 | -2,747,000 | -3,050,000 | -2,519,000 | -2,107,000 | -1,071,000 | -1,366,000 | -1,333,000 | -1,087,000 | -575,000 | -789,000 | -899,000 |
net gain on sale of other real estate owned and repossessed assets | -318,000 | 0 | -95,000 | 0 | 33,000 | 6,000 | 0 | -52,000 | 334,000 | 0 | -7,000 | |||||||||||||||
increase in cash surrender value of life insurance contracts | -2,137,000 | -1,614,000 | 1,173,000 | -3,231,000 | -1,639,000 | -1,818,000 | -2,496,000 | -1,621,000 | -1,600,000 | -1,637,000 | -1,633,000 | -1,608,000 | -1,630,000 | -1,671,000 | -1,683,000 | -1,658,000 | -1,660,000 | -1,733,000 | -1,464,000 | -1,453,000 | -1,419,000 | -787,000 | -778,000 | -762,000 | -787,000 | -724,000 |
net change in other assets, liabilities, and other operating activities | -16,125,000 | 11,748,000 | -5,662,000 | 500,000 | 33,860,000 | -34,826,000 | -25,442,000 | -10,652,000 | 3,094,000 | -9,807,000 | -21,188,000 | 1,921,000 | 7,134,000 | -2,516,000 | -10,341,000 | 6,462,000 | 12,748,000 | -27,897,000 | 13,167,000 | 2,814,000 | 15,611,000 | -7,126,000 | -15,190,000 | 2,550,000 | -370,000 | 3,202,000 |
net cash from operating activities | 47,954,000 | 84,023,000 | 48,251,000 | 53,473,000 | 91,084,000 | 12,719,000 | 38,344,000 | 55,149,000 | 73,842,000 | 72,786,000 | 56,734,000 | 69,265,000 | 70,845,000 | 66,033,000 | 62,693,000 | 66,760,000 | 73,790,000 | 12,866,000 | 52,402,000 | 52,232,000 | 61,441,000 | 41,533,000 | 19,627,000 | 41,674,000 | 38,973,000 | 29,214,000 |
investment activities | ||||||||||||||||||||||||||
purchases of debt securities available-for-sale | -114,929,000 | 0 | -443,078,000 | -198,269,000 | -375,083,000 | -212,672,000 | ||||||||||||||||||||
proceeds from maturities, calls and paydowns of debt securities available-for-sale | 82,077,000 | 59,102,000 | 342,735,000 | 24,724,000 | 309,875,000 | 390,320,000 | ||||||||||||||||||||
purchases of debt securities held-to-maturity | 0 | -35,536,000 | -9,936,000 | 0 | 0 | |||||||||||||||||||||
proceeds from maturities, calls and paydowns of debt securities held-to-maturity | 13,001,000 | 38,174,000 | 135,977,000 | 124,904,000 | 61,235,000 | 13,790,000 | ||||||||||||||||||||
purchases of restricted equity securities | -856,000 | 0 | 0 | -1,074,000 | 0 | -33,732,000 | 0 | -12,750,000 | 0 | 0 | 0 | -423,000 | ||||||||||||||
investment in tax credit partnerships and sbic | 1,201,000 | -466,000 | -8,775,000 | -25,000 | -2,000,000 | -1,486,000 | -5,279,000 | -538,000 | ||||||||||||||||||
net increase in loans | -287,124,000 | |||||||||||||||||||||||||
purchases of premises and equipment | -1,469,000 | -3,584,000 | -1,038,000 | -1,077,000 | -1,003,000 | -960,000 | -633,000 | -1,314,000 | -1,715,000 | -655,000 | -614,000 | -666,000 | ||||||||||||||
proceeds from sale of other real estate owned and repossessed assets | 2,117,000 | 1,063,000 | 90,000 | 690,000 | 0 | 0 | 1,042,000 | 149,000 | 1,047,000 | 44,000 | 1,784,000 | 150,000 | 177,000 | 584,000 | 1,073,000 | 928,000 | 398,000 | 454,000 | 710,000 | 679,000 | 0 | 48,000 | 320,000 | 426,000 | ||
net cash from investing activities | -305,982,000 | 83,051,000 | -465,828,000 | -283,862,000 | -27,541,000 | 148,346,000 | -407,213,000 | 85,976,000 | -380,995,000 | -629,898,000 | -912,504,000 | -718,820,000 | -1,081,676,000 | -150,125,000 | -209,585,000 | -119,708,000 | 39,301,000 | -303,506,000 | -780,995,000 | -365,871,000 | -376,527,000 | -111,392,000 | -332,454,000 | -167,976,000 | -236,174,000 | -290,011,000 |
financing activities | ||||||||||||||||||||||||||
net increase in non-interest-bearing deposits | 27,890,000 | -422,611,000 | -340,589,000 | -1,024,575,000 | -202,984,000 | 89,728,000 | 433,113,000 | 1,070,225,000 | 251,818,000 | 255,839,000 | 25,958,000 | 83,921,000 | 753,267,000 | 175,747,000 | 71,207,000 | 101,713,000 | 4,256,000 | 15,362,000 | 23,000,000 | 10,835,000 | ||||||
net increase in interest-bearing deposits | 857,712,000 | -213,777,000 | 660,168,000 | -506,601,000 | 109,106,000 | 1,088,187,000 | 716,536,000 | 491,123,000 | 835,479,000 | 304,153,000 | -433,434,000 | -133,809,000 | -58,947,000 | 50,209,000 | 128,808,000 | 346,047,000 | 275,983,000 | 246,944,000 | 756,996,000 | 126,475,000 | -264,932,000 | 217,651,000 | 316,872,000 | 152,596,000 | -69,614,000 | |
net increase in federal funds purchased | 364,598,000 | 88,604,000 | 152,476,000 | 77,155,000 | -250,071,000 | -72,539,000 | 425,021,000 | 227,282,000 | 147,916,000 | 60,013,000 | 182,195,000 | 33,744,000 | 91,983,000 | 72,874,000 | 100,518,000 | -89,218,000 | 86,071,000 | 84,653,000 | 2,297,000 | |||||||
proceeds from exercise of stock options | 230,000 | 236,000 | 239,000 | 130,000 | 273,000 | 0 | 168,000 | 846,000 | 153,000 | 217,000 | 309,000 | 553,000 | 315,000 | 159,000 | 1,195,000 | 1,865,000 | 315,000 | 728,000 | 183,000 | 2,261,000 | 448,000 | 573,000 | 305,000 | 797,000 | 465,000 | 926,000 |
taxes paid in net settlement of tax obligation upon exercise of stock options | -1,036,000 | -95,000 | -182,000 | -133,000 | -137,000 | 0 | -122,000 | -1,716,000 | -14,000 | -189,000 | -327,000 | -613,000 | -111,000 | -99,000 | -928,000 | -1,710,000 | -102,000 | -224,000 | 0 | -403,000 | -235,000 | -289,000 | 0 | -1,453,000 | -370,000 | |
dividends paid on common stock | -18,280,000 | -16,355,000 | -16,353,000 | -16,338,000 | -15,239,000 | -28,000 | -15,233,000 | -15,211,000 | -12,594,000 | 81,000 | -12,485,000 | -12,472,000 | -10,919,000 | 26,000 | -10,840,000 | -10,787,000 | -9,408,000 | -29,000 | -9,409,000 | -9,384,000 | -8,015,000 | 6,000 | -8,025,000 | -8,019,000 | -5,848,000 | -2,105,000 |
net cash from financing activities | 1,231,114,000 | 316,392,000 | 243,443,000 | -449,800,000 | 2,436,000 | 926,352,000 | 475,590,000 | -86,207,000 | 634,880,000 | -643,158,000 | 788,441,000 | 1,347,802,000 | 517,938,000 | 651,267,000 | 474,949,000 | 365,084,000 | 1,592,989,000 | 367,570,000 | -101,041,000 | 230,436,000 | 399,448,000 | 243,936,000 | 397,351,000 | -57,636,000 | ||
net increase in cash and cash equivalents | 973,086,000 | 483,466,000 | -174,134,000 | -680,189,000 | 65,979,000 | 1,087,417,000 | 106,721,000 | 54,918,000 | 327,727,000 | -1,200,270,000 | -1,754,793,000 | -778,707,000 | -222,390,000 | 1,263,710,000 | 371,046,000 | 598,319,000 | 588,040,000 | 74,444,000 | 864,396,000 | 53,931,000 | -416,127,000 | 160,577,000 | 86,621,000 | 117,634,000 | -318,433,000 | |
cash and cash equivalents at beginning of period | 2,376,634,000 | 0 | 0 | 2,131,088,000 | 0 | 0 | 0 | 816,053,000 | 0 | 0 | 0 | 4,222,096,000 | 0 | 0 | 0 | 2,211,411,000 | 0 | 0 | 0 | 630,600,000 | 0 | 0 | 0 | 681,895,000 | 0 | 783,997,000 |
cash and cash equivalents at end of period | 3,349,720,000 | 483,466,000 | -174,134,000 | 1,450,899,000 | 65,979,000 | 1,087,417,000 | 106,721,000 | 870,971,000 | 327,727,000 | -1,200,270,000 | -1,754,793,000 | 3,443,389,000 | -222,390,000 | 1,263,710,000 | 371,046,000 | 2,809,730,000 | 588,040,000 | 74,444,000 | 864,396,000 | 684,531,000 | -416,127,000 | 160,577,000 | 86,621,000 | 799,529,000 | 200,150,000 | 465,564,000 |
supplemental disclosure | ||||||||||||||||||||||||||
cash paid for: | ||||||||||||||||||||||||||
interest | 116,514,000 | 131,570,000 | 123,194,000 | 124,938,000 | 124,513,000 | 111,886,000 | 85,885,000 | 71,095,000 | 44,155,000 | 28,981,000 | 3,391,000 | 6,900,000 | 6,882,000 | 7,308,000 | 8,827,000 | 7,487,000 | 8,578,000 | 10,823,000 | 12,535,000 | 18,662,000 | 21,952,000 | 27,579,000 | 28,248,000 | 23,826,000 | 15,855,000 | 7,652,000 |
income taxes | 3,129,000 | 6,431,000 | 20,157,000 | 6,977,000 | 0 | 7,023,000 | 45,048,000 | 1,920,000 | 13,290,000 | 52,134,000 | 2,350,000 | 891,000 | 38,503,000 | 12,720,000 | 1,134,000 | 4,294,000 | 12,274,000 | 38,386,000 | -193,000 | 400,000 | 7,768,000 | 9,508,000 | 23,423,000 | 1,533,000 | 10,770,000 | 652,000 |
noncash transactions | ||||||||||||||||||||||||||
other real estate acquired in settlement of loans | 24,000 | 2,383,000 | 1,058,000 | 90,000 | 305,000 | -109,000 | 1,000 | 188,000 | 27,000 | 830,000 | 899,000 | 1,055,000 | 0 | 364,000 | 539,000 | 1,383,000 | 736,000 | 287,000 | 3,434,000 | 425,000 | 371,000 | 381,000 | 455,000 | 553,000 | ||
dividends on nonvested restricted stock reclassified as compensation expense | 66,000 | 0 | 56,000 | 100,000 | 0 | 41,000 | 33,000 | 35,000 | 32,000 | 33,000 | ||||||||||||||||
dividends declared | 18,292,000 | 9,000 | 3,000 | 16,353,000 | 1,099,000 | 0 | 6,000 | 15,233,000 | 2,717,000 | 3,000 | 6,000 | 12,485,000 | 1,630,000 | -7,000 | 20,000 | 10,829,000 | 1,365,000 | 9,000 | 4,000 | 9,409,000 | 1,347,000 | 7,000 | 5,000 | 8,025,000 | 3,000 | 2,641,000 |
see notes to consolidated financial statements. | ||||||||||||||||||||||||||
net amortization of debt securities available-for-sale | 77,000 | -114,000 | -197,000 | -173,000 | -4,000 | |||||||||||||||||||||
net (gain) loss on sale of other real estate owned and repossessed assets | -262,000 | 0 | -238,000 | -1,000 | 0 | -24,000 | -116,000 | -36,000 | ||||||||||||||||||
write down of other real estate owned and repossessed assets | 218,000 | 1,000 | 0 | 6,000 | -31,000 | 115,000 | 614,000 | 147,000 | 25,000 | 0 | 1,249,000 | 587,000 | -1,000 | 66,000 | 202,000 | 20,000 | 235,000 | |||||||||
proceeds from sale of restricted equity securities | 0 | 30,813,000 | 0 | 13,177,000 | ||||||||||||||||||||||
return of capital from tax credit partnerships and sbic | 135,000 | 0 | ||||||||||||||||||||||||
increase in loans | -11,373,000 | -456,342,000 | -223,799,000 | -411,209,000 | -664,450,000 | -719,043,000 | -369,412,000 | -721,763,000 | -165,094,000 | -145,313,000 | -40,193,000 | 33,006,000 | -205,813,000 | -751,465,000 | -312,426,000 | -249,309,000 | -63,193,000 | -312,054,000 | -129,977,000 | -238,169,000 | -243,562,000 | |||||
proceeds from death benefit of bank owned life insurance contracts | 0 | 353,000 | ||||||||||||||||||||||||
net decrease in non-interest-bearing deposits | 100,914,000 | -152,224,000 | -15,462,000 | -234,030,000 | ||||||||||||||||||||||
fhlb advances | 0 | 0 | 0 | 300,000,000 | ||||||||||||||||||||||
repayment of fhlb advances | 0 | 0 | 0 | -300,000,000 | ||||||||||||||||||||||
dividends paid on preferred stock | 0 | -31,000 | 0 | -31,000 | 0 | -31,000 | 0 | -32,000 | 0 | -32,000 | 0 | 0 | ||||||||||||||
deferred tax benefit | -137,000 | |||||||||||||||||||||||||
net decrease in federal funds purchased | 72,223,000 | -182,094,000 | -138,638,000 | -16,565,000 | ||||||||||||||||||||||
deferred benefit tax | 2,626,000 | |||||||||||||||||||||||||
amortization of core deposit intangible | 0 | 0 | 0 | 23,000 | 67,000 | 68,000 | 68,000 | 67,000 | 68,000 | 67,000 | 68,000 | 68,000 | 67,000 | 68,000 | 67,000 | 68,000 | 67,000 | 72,000 | ||||||||
gain on sale of securities available for sale | 0 | 0 | ||||||||||||||||||||||||
operating incomees of tax credit partnerships | 0 | 0 | 0 | 4,000 | 1,000 | 3,000 | 38,000 | 35,000 | 58,000 | |||||||||||||||||
proceeds from sale of debt securities available-for-sale | ||||||||||||||||||||||||||
decrease (increase) in loans | -20,565,000 | -40,484,000 | 20,775,000 | 56,588,000 | ||||||||||||||||||||||
purchase of bank owned life insurance contracts | -20,682,000 | |||||||||||||||||||||||||
expenditures for other real estate owned | 0 | |||||||||||||||||||||||||
cash paid/(received) for: | ||||||||||||||||||||||||||
income tax refund | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -181,000 | ||||||||||||||||||
internally financed sale of other real estate owned | 0 | 0 | 0 | 3,779,000 | ||||||||||||||||||||||
debt securities available for sale transferred to held to maturity | ||||||||||||||||||||||||||
loss on sale of securities available for sale | 3,335,000 | |||||||||||||||||||||||||
deferred tax | 263,000 | 49,000 | -3,091,000 | 52,000 | 5,681,000 | -5,257,000 | -5,073,000 | 0 | -369,000 | |||||||||||||||||
adjustments to reconcile net income to net cash provided by | ||||||||||||||||||||||||||
net amortization of debt securities available for sale | 128,000 | 229,000 | 290,000 | -2,241,000 | 4,303,000 | 7,209,000 | 4,578,000 | 1,177,000 | 1,701,000 | 1,771,000 | 1,552,000 | 1,316,000 | 966,000 | 1,055,000 | 736,000 | 678,000 | 626,000 | 1,049,000 | 1,001,000 | |||||||
purchases of debt securities available for sale | 0 | 0 | -23,860,000 | -52,500,000 | ||||||||||||||||||||||
proceeds from maturities, calls and paydowns of debt securities available for sale | 18,853,000 | 20,059,000 | 31,232,000 | 34,832,000 | 29,627,000 | -11,393,000 | 54,605,000 | 72,787,000 | 64,929,000 | 56,499,000 | 26,778,000 | 23,319,000 | ||||||||||||||
proceeds from sale of debt securities available for sale | 0 | 0 | 29,642,000 | 45,394,000 | 636,000 | |||||||||||||||||||||
purchases of debt securities held to maturity | 0 | 0 | -255,644,000 | -392,622,000 | ||||||||||||||||||||||
proceeds from maturities, calls and paydowns of debt securities held to maturity | 11,960,000 | 14,457,000 | 16,583,000 | |||||||||||||||||||||||
adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||||||||||||
amortization of investments in tax credit partnerships | ||||||||||||||||||||||||||
proceeds from issuance of 4% subordinated notes due october 21, 2030, net of issuance cost | ||||||||||||||||||||||||||
repayment of 5% subordinated notes due july 15, 2025 | ||||||||||||||||||||||||||
increase in accrued interest payable | 566,000 | 922,000 | 544,000 | 406,000 | 205,000 | -689,000 | 465,000 | 458,000 | 546,000 | -546,000 | 1,095,000 | 1,340,000 | -187,000 | |||||||||||||
investment in tax credit partnership and sbic | -14,649,000 | -1,581,000 | -65,000 | -33,366,000 | -10,490,000 | 0 | -56,000 | 0 | -93,000 | -432,000 | -111,000 | |||||||||||||||
return of capital from tc partnerships and sbic | 185,000 | 0 | 249,000 | |||||||||||||||||||||||
decrease in accrued interest payable | ||||||||||||||||||||||||||
decrease in accrued interest and dividends receivable | 443,000 | |||||||||||||||||||||||||
proceeds from maturities and paydowns of debt securities held to maturity | 21,554,000 | |||||||||||||||||||||||||
net cash (used-in) provided by financing activities | -129,152,000 | |||||||||||||||||||||||||
decrease (increase) in accrued interest and dividends receivable | -1,016,000 | 948,000 | ||||||||||||||||||||||||
gain on call of securities available for sale | 0 | 0 | ||||||||||||||||||||||||
purchase of debt securities available for sale | -118,219,000 | -35,037,000 | -113,928,000 | -149,719,000 | -46,143,000 | -122,826,000 | -85,478,000 | -80,149,000 | -107,592,000 | -64,650,000 | -22,103,000 | |||||||||||||||
purchase of premises and equipment | -391,000 | 5,741,000 | -12,281,000 | -2,518,000 | -740,000 | -631,000 | -517,000 | -417,000 | -834,000 | -304,000 | -459,000 | -759,000 | -452,000 | -6,844,000 | ||||||||||||
available-for-sale securities transferred to held-to-maturity portfolio | 0 | |||||||||||||||||||||||||
proceeds from maturities, calls and paydowns of debt securities | ||||||||||||||||||||||||||
available for sale | 72,194,000 | |||||||||||||||||||||||||
gain on sale of equity securities | ||||||||||||||||||||||||||
net gain on sale of debt securities available for sale | 1,000 | -34,000 | ||||||||||||||||||||||||
purchase of debt securities held to maturity | 0 | 0 | 0 | -250,000 | ||||||||||||||||||||||
repayment of federal home loan bank advances | 0 | -100,000 | ||||||||||||||||||||||||
redemption of 5% subordinated notes due july 15, 2025 | ||||||||||||||||||||||||||
deferred tax (benefit) expense | -3,515,000 | 107,000 | -1,267,000 | |||||||||||||||||||||||
benefit from loan losses | 12,284,000 | 10,283,000 | 13,584,000 | 5,884,000 | 6,985,000 | 4,884,000 | 4,885,000 | 6,624,000 | 4,986,000 | |||||||||||||||||
operating income (income) of tax credit partnerships | ||||||||||||||||||||||||||
net income on sale of debt securities available for sale | ||||||||||||||||||||||||||
proceeds from sale of equity securities | 275,000 | |||||||||||||||||||||||||
purchase of boli contracts | -55,000,000 | |||||||||||||||||||||||||
expenditures to complete construction of other real estate owned | ||||||||||||||||||||||||||
operating (income) loss of tax credit partnerships | ||||||||||||||||||||||||||
proceeds from maturities, calls and paydowns of debt securities available for sale | ||||||||||||||||||||||||||
net income on sale of other real estate owned and repossessed assets | 0 | 2,000 | ||||||||||||||||||||||||
purchase of securities available for sale | -65,507,000 | -53,885,000 | ||||||||||||||||||||||||
proceeds from maturities, calls and paydowns of securities available for sale | 28,469,000 | 23,357,000 | ||||||||||||||||||||||||
gain on sale of debt securities available for sale | -11,000 | |||||||||||||||||||||||||
purchase of equity securities | -10,000 | |||||||||||||||||||||||||
purchase of bank-owned life insurance contracts | ||||||||||||||||||||||||||
proceeds from sale of preferred stock | 125,000 | |||||||||||||||||||||||||
net decrease in cash and cash equivalents | 200,150,000 | |||||||||||||||||||||||||
internally financed sales of other real estate owned | 49,000 | |||||||||||||||||||||||||
net decrease in interest-bearing deposits | ||||||||||||||||||||||||||
investment in tax credit partnerships | ||||||||||||||||||||||||||
net cash paid in acquisition of metro bancshares, inc. | ||||||||||||||||||||||||||
proceeds from issuance of 5% subordinated notes due july 15, 2025 | ||||||||||||||||||||||||||
redemption of series a senior non-cumulative preferred stock | ||||||||||||||||||||||||||
proceeds from issuance of 4.5% subordinated notes due november 8, 2027, net of issuance cost | ||||||||||||||||||||||||||
repayment of 5.5% subordinated notes due november 9, 2022 | ||||||||||||||||||||||||||
taxes paid in net settlement upon exercise of stock options | ||||||||||||||||||||||||||
capitalized cost of shelf registration | ||||||||||||||||||||||||||
cash and cash equivalents at beginning of year | ||||||||||||||||||||||||||
cash and cash equivalents at end of year | ||||||||||||||||||||||||||
fair value of assets and liabilities from acquisition: | ||||||||||||||||||||||||||
fair value of tangible assets acquired | ||||||||||||||||||||||||||
intangible assets acquired | ||||||||||||||||||||||||||
fair value of liabilities assumed | ||||||||||||||||||||||||||
net identifiable assets acquired over liabilities assumed | ||||||||||||||||||||||||||
losses of tax credit partnerships | -22,000 | |||||||||||||||||||||||||
purchase of securities held to maturity | -9,786,000 | |||||||||||||||||||||||||
proceeds from maturities, calls and paydowns of securities held to maturity | 293,000 | |||||||||||||||||||||||||
adjustments to reconcile net income to net cash provided by: | ||||||||||||||||||||||||||
net income on sale of other real estate owned | ||||||||||||||||||||||||||
write down of other real estate owned | ||||||||||||||||||||||||||
operating incomees on tax credit and other partnerships | ||||||||||||||||||||||||||
net increase in noninterest-bearing deposits | ||||||||||||||||||||||||||
other intangible assets acquired | ||||||||||||||||||||||||||
total merger consideration | ||||||||||||||||||||||||||
losses on tax credit partnerships | ||||||||||||||||||||||||||
excess tax benefits from exercise of stock options and warrants | ||||||||||||||||||||||||||
net change in other assets, liabilities, and other | ||||||||||||||||||||||||||
held to maturity | ||||||||||||||||||||||||||
proceeds from sale of common stock | ||||||||||||||||||||||||||
costs to issue shelf registration | ||||||||||||||||||||||||||
proceeds from exercise of stock options and warrants | ||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||
accretion | ||||||||||||||||||||||||||
excess tax benefits from the exercise and vesting of stock options | ||||||||||||||||||||||||||
increase in noninterest-bearing deposits | ||||||||||||||||||||||||||
increase in interest-bearing deposits | ||||||||||||||||||||||||||
increase in federal funds purchased | ||||||||||||||||||||||||||
paydown of federal home loan bank advance | ||||||||||||||||||||||||||
proceeds from sale of preferred shares | ||||||||||||||||||||||||||
dividends on common stock | ||||||||||||||||||||||||||
dividends on preferred stock | ||||||||||||||||||||||||||
operating activities: | ||||||||||||||||||||||||||
depreciation and amortization | ||||||||||||||||||||||||||
net amortization of investments | ||||||||||||||||||||||||||
market value adjustment of interest rate cap | ||||||||||||||||||||||||||
net (gain) loss on sale of other real estate owned | ||||||||||||||||||||||||||
decrease in special prepaid fdic insurance assessments | ||||||||||||||||||||||||||
loss on prepayment of other borrowings | ||||||||||||||||||||||||||
proceeds from maturities, calls and paydowns of securities | ||||||||||||||||||||||||||
purchase of restricted equity securities | ||||||||||||||||||||||||||
purchase of interest rate cap | ||||||||||||||||||||||||||
proceeds from sale of securities available for sale | ||||||||||||||||||||||||||
proceeds from sale of other real estate owned and repossessions | ||||||||||||||||||||||||||
additions to other real estate owned | ||||||||||||||||||||||||||
proceeds from issuance of trust preferred securities | ||||||||||||||||||||||||||
repayment of other borrowings | ||||||||||||||||||||||||||
transfers of loans from held for sale to held for investment | ||||||||||||||||||||||||||
net amortization (accretion) of investments | ||||||||||||||||||||||||||
stock compensation expense | ||||||||||||||||||||||||||
proceeds from sale restricted equity securities | ||||||||||||||||||||||||||
proceeds from sale of interest rate floor | ||||||||||||||||||||||||||
proceeds from tenant reimbursement | ||||||||||||||||||||||||||
amortized gain on derivative | ||||||||||||||||||||||||||
decrease (increase) in special prepaid | ||||||||||||||||||||||||||
fdic insurance assessments | ||||||||||||||||||||||||||
proceeds from other borrowings | ||||||||||||||||||||||||||
proceeds from sale of stock | ||||||||||||||||||||||||||
loss on disposal of premises and equipment | ||||||||||||||||||||||||||
proceeds from disposal of premises and equipment | ||||||||||||||||||||||||||
write-down of other real estate owned | ||||||||||||||||||||||||||
net accretion of investments | ||||||||||||||||||||||||||
loss on sale of other real estate owned | ||||||||||||||||||||||||||
increase in special prepaid fdic insurance assessments | ||||||||||||||||||||||||||
loss on sale of other real estate | ||||||||||||||||||||||||||
proceeds from mortgage loans held for sale | ||||||||||||||||||||||||||
proceeds from maturities, calls and paydowns of securities available | ||||||||||||||||||||||||||
for sale | ||||||||||||||||||||||||||
write-down of investment in limited partnership | ||||||||||||||||||||||||||
purchase of interest rate floor | ||||||||||||||||||||||||||
net increase in non-interest bearing deposits | ||||||||||||||||||||||||||
repayments and maturities of borrowings | ||||||||||||||||||||||||||
net proceeds from issuance of trust preferred securities | ||||||||||||||||||||||||||
finance sale of other real estate owned | ||||||||||||||||||||||||||
proceeds from sale of mortgages held for sale | ||||||||||||||||||||||||||
originations of mortgages held for sale | ||||||||||||||||||||||||||
(gain) loss on sale of other real estate | ||||||||||||||||||||||||||
net change in other operating activities | ||||||||||||||||||||||||||
investing activities | ||||||||||||||||||||||||||
purchases of securities available for sale | ||||||||||||||||||||||||||
proceeds from maturities/calls, pay downs of securities available for sale | ||||||||||||||||||||||||||
proceeds from sale of other real estate | ||||||||||||||||||||||||||
net increase in interest bearing deposits | ||||||||||||||||||||||||||
proceeds from issuance of common shares | ||||||||||||||||||||||||||
proceeds from sale of derivative |
We provide you with 20 years of cash flow statements for ServisFirst Bancshares stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ServisFirst Bancshares stock. Explore the full financial landscape of ServisFirst Bancshares stock with our expertly curated income statements.
The information provided in this report about ServisFirst Bancshares stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.